Synthesis and biological evaluation of imidazo[4,5-b]pyridine and 4-heteroaryl-pyrimidine derivatives as anti-cancer agents
Lukasik, Pawel M., Elabar, Sherifa, Lam, Frankie, Shao, Hao, Liu, Xiangrui, Abbas, Abdullah Y., Wang, Shudong
Published in European journal of medicinal chemistry (01.11.2012)
Published in European journal of medicinal chemistry (01.11.2012)
Get full text
Journal Article
A novel Cdk9 inhibitor preferentially targets tumor cells and synergizes with fludarabine
Walsby, Elisabeth, Pratt, Guy, Shao, Hao, Abbas, Abdullah Y, Fischer, Peter M, Bradshaw, Tracey D, Brennan, Paul, Fegan, Chris, Wang, Shudong, Pepper, Chris
Published in Oncotarget (30.01.2014)
Published in Oncotarget (30.01.2014)
Get full text
Journal Article
Synthesis, structure–activity relationship and biological evaluation of 2,4,5-trisubstituted pyrimidine CDK inhibitors as potential anti-tumour agents
Shao, Hao, Shi, Shenhua, Foley, David W., Lam, Frankie, Abbas, Abdullah Y., Liu, Xiangrui, Huang, Shiliang, Jiang, Xiangrui, Baharin, Nadiah, Fischer, Peter M., Wang, Shudong
Published in European journal of medicinal chemistry (01.12.2013)
Published in European journal of medicinal chemistry (01.12.2013)
Get full text
Journal Article